Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/18891Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Drosos, A. A. | en |
| dc.contributor.author | Sakkas, L. I. | en |
| dc.contributor.author | Goussia, A. | en |
| dc.contributor.author | Siamopoulos, K. C. | en |
| dc.contributor.author | Moutsopoulos, H. M. | en |
| dc.date.accessioned | 2015-11-24T18:55:30Z | - |
| dc.date.available | 2015-11-24T18:55:30Z | - |
| dc.identifier.issn | 0954-6820 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18891 | - |
| dc.rights | Default Licence | - |
| dc.subject | Administration, Oral | en |
| dc.subject | Adolescent | en |
| dc.subject | Adult | en |
| dc.subject | Aged | en |
| dc.subject | Cyclophosphamide/*administration & dosage/therapeutic use | en |
| dc.subject | Drug Administration Schedule | en |
| dc.subject | Humans | en |
| dc.subject | Infusions, Intravenous | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Pilot Projects | en |
| dc.subject | Treatment Outcome | en |
| dc.subject | Wegener Granulomatosis/*drug therapy | en |
| dc.title | Pulse cyclophosphamide therapy in Wegener's granulomatosis: a pilot study | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/1402626 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1992 | - |
| heal.abstract | Five patients with Wegener's granulomatosis (WG) have been treated with 6- to 8-monthly pulses of intravenous cyclophosphamide (CP) and glucocorticoids in an open pilot study. One patient achieved complete remission sustained during 30 months of follow-up; one patient had features of active disease after 28 months of remission; two patients after an initial remission had an exacerbation of the disease and received continuous oral administration of CP, and one patient required continuous oral CP to control the symptoms. These results suggest that this regimen may not achieve a high degree of sustained remission in patients with WG. | en |
| heal.journalName | J Intern Med | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
